Clopidogrel (Plavix) will compete with prasugrel (Effient)

Clopidogrel (Plavix) will compete with prasugrel (Effient) if it's approved...as early as this summer.

They're both in the same class...thienopyridines.

Prasugrel seems to be more effective than clopidogrel...for reducing cardiovascular events in some acute coronary syndrome patients undergoing angioplasty.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote